Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants.

[1]  H. Haas,et al.  Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors , 2007, Neuropharmacology.

[2]  R. C. Pierce,et al.  The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? , 2006, Neuroscience & Biobehavioral Reviews.

[3]  T. Spencer,et al.  Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the Transporters and Trace Amine Activity in Vitro , 2006, Journal of Pharmacology and Experimental Therapeutics.

[4]  Dennis K. Miller,et al.  Interaction of lobeline and nicotinic receptor ligands with the discriminative stimulus properties of cocaine and amphetamine. , 2006, Drug and alcohol dependence.

[5]  M. Krebs,et al.  Neuroprotective agents in schizophrenia and affective disorders , 2006, Expert opinion on pharmacotherapy.

[6]  J. Ballon,et al.  A systematic review of modafinil: Potential clinical uses and mechanisms of action. , 2006, The Journal of clinical psychiatry.

[7]  Steven R. Goldberg,et al.  Nicotine as a typical drug of abuse in experimental animals and humans , 2006, Psychopharmacology.

[8]  J. Wisor,et al.  Dopaminergic—adrenergic interactions in the wake promoting mechanism of modafinil , 2005, Neuroscience.

[9]  S. Casteel,et al.  Dietary cadmium exposure attenuates d-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity , 2005, Pharmacology Biochemistry and Behavior.

[10]  D. Sulzer,et al.  Mechanisms of neurotransmitter release by amphetamines: A review , 2005, Progress in Neurobiology.

[11]  S. Nasr.  Modafinil as adjunctive therapy in depressed outpatients. , 2004, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[12]  H. Myrick,et al.  Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues. , 2004, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[13]  K. Lynch,et al.  Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. , 2003, Drug and alcohol dependence.

[14]  T. Kelly,et al.  Discriminative-stimulus effects of modafinil in cocaine-trained humans. , 2002, Drug and alcohol dependence.

[15]  M. Le Moal,et al.  Study of the addictive potential of modafinil in naive and cocaine-experienced rats , 2002, Psychopharmacology.

[16]  H. Mansvelder,et al.  Synaptic Mechanisms Underlie Nicotine-Induced Excitability of Brain Reward Areas , 2002, Neuron.

[17]  R. Papke,et al.  Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. , 2001, The Journal of pharmacology and experimental therapeutics.

[18]  A. Célérier,et al.  First evidence of a delay-dependent working memory-enhancing effect of modafinil in mice , 2001, Neuroreport.

[19]  G. Bratton,et al.  Dietary cadmium exposure alters characteristics of training, substitution, and tolerance when morphine is used as a discriminative stimulus. , 2000, Neurotoxicology.

[20]  D. Jasinski,et al.  Evaluation of the Abuse Liability of Modafinil and Other Drugs for Excessive Daytime Sleepiness Associated with Narcolepsy , 2000, Clinical neuropharmacology.

[21]  F. Colpaert,et al.  Drug Discrimination in Neurobiology , 1998, Pharmacology Biochemistry and Behavior.

[22]  D. Edgar,et al.  Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. , 1997, The Journal of pharmacology and experimental therapeutics.

[23]  L. Teng,et al.  Nicotinic-receptor mediation of S(-)nornicotine-evoked -3H-overflow from rat striatal slices preloaded with -3H-dopamine. , 1997, The Journal of pharmacology and experimental therapeutics.

[24]  M. D. Schechter.  Discriminative Characteristics of High and Low Cocaine Administration: Effect of Other Psychostimulants , 1997, Pharmacology Biochemistry and Behavior.

[25]  L. Gold,et al.  Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil , 1996, Psychopharmacology.

[26]  K. Fuxe,et al.  The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. , 1996, European journal of pharmacology.

[27]  J. Costentin,et al.  Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice , 1995, European Neuropsychopharmacology.

[28]  I.P. Stolerman,et al.  A bibliography of drug discrimination research, 1992-1994. , 1995, Behavioural pharmacology.

[29]  C. Guilleminault,et al.  Modafinil binds to the dopamine uptake carrier site with low affinity. , 1994, Sleep.

[30]  F. Rambert,et al.  Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: In vivo voltammetry studies , 1994, Neuropharmacology.

[31]  M. Jouvet,et al.  Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity , 1991, Neuroscience Letters.

[32]  D. Gauvin,et al.  Behavioral interaction between cocaine and caffeine: A drug discrimination analysis in rats , 1989, Pharmacology Biochemistry and Behavior.

[33]  B. Westerink,et al.  Effect of Various Centrally Acting Drugs on the Efflux of Dopamine Metabolites from the Rat Brain , 1986, Journal of neurochemistry.

[34]  M. Branch.  Rate dependency, behavioral mechanisms, and behavioral pharmacology. , 1984, Journal of the experimental analysis of behavior.

[35]  F. J. White,et al.  Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures , 1982, Neuroscience & Biobehavioral Reviews.

[36]  J. Raynaud,et al.  Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum , 1974, The Journal of pharmacy and pharmacology.

[37]  K. Lynch,et al.  A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence , 2005, Neuropsychopharmacology.

[38]  M. Reith,et al.  Structure-Function Relationships for Biogenic Amine Neurotransmitter Transporters , 2002 .

[39]  S. Nishino,et al.  Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. , 1998, Sleep research online : SRO.

[40]  E. Corruble,et al.  Subjective effects of modafinil, a new central adrenergic stimulant in healthy volunteers: a comparison with amphetamine, caffeine and placebo , 1993, European Psychiatry.